Celiac Disease Database
NCT01172665 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1090
Last updated 2024-05-16
Summary
The focus of this study is to create a database containing information about patients with celiac disease. This database will allow us to examine clinical and epidemiologic features of the University of Chicago Medical Center patient population. We have the largest population of patients with celiac disease in the mid-West and as such this study using information gathered from our database can greatly contribute to our current understanding of this disease.
Conditions
Sponsors & Collaborators
-
University of Chicago
lead OTHER
Principal Investigators
-
Ritu Verma, MD · University of Chicago
Eligibility
- Min Age
- 0 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-09-30
- Primary Completion
- 2024-05-01
- Completion
- 2024-05-05
Countries
- United States
Study Locations
More Related Trials
-
Risk Factors for the Development of Celiac Disease in Genetically Predisposed Children
NCT04034303 ·Status: UNKNOWN
-
Dietary Assessment and Mycotoxin Exposure in Celiac Disease
NCT01975155 ·Status: UNKNOWN
-
Virtual Celiac Symptoms Study in Adults and Teenagers
NCT05309330 ·Status: COMPLETED
-
Pre-endoscopy Serological Testing for Coeliac Disease; a Novel Approach Using Rapid Antibody Testing
NCT02834429 ·Status: COMPLETED
-
A Pilot Study to Explore the Role of Gut Flora in Celiac Disease
NCT04148235 ·Status: WITHDRAWN
-
Prospective Study of Undiagnosed Celiac Disease
NCT01317914 ·Status: COMPLETED ·Phase: NA
-
Improved Diagnostics of Celiac Disease in Children
NCT02072590 ·Status: COMPLETED
-
Virtual Dietetic Interventions in Patients With Coeliac
NCT07172555 ·Status: RECRUITING ·Phase: NA
-
Gluten Technology and Education for Celiac Health
NCT06059716 ·Status: RECRUITING ·Phase: NA
-
Effect of UGIR in Adults With Compromised Gut Function and Malabsorption
NCT03011593 ·Status: COMPLETED ·Phase: NA
-
Interpretation of Serological Tests in the Diagnosis of Celiac Disease: Anti-deamidated Gliadin Peptide Antibodies Revisited
NCT03320811 ·Status: COMPLETED
-
Celiac Disease Genomic Environmental Microbiome and Metabolomic Study
NCT02061306 ·Status: RECRUITING
-
Treatment of Screen-detected Celiac Disease
NCT01116505 ·Status: COMPLETED ·Phase: NA
-
Celiac Disease Prevention
NCT00617838 ·Status: UNKNOWN ·Phase: NA
-
Validation of a New Innovative Method for Specific Marker Detection in Celiac Disease
NCT06324539 ·Status: RECRUITING
-
Celiac Disease: Nutrition Education in Primary School
NCT05467865 ·Status: COMPLETED ·Phase: NA
-
FREQUENCY OF FIBROMYALGIA IN PATIENTS WITH CELIAC DISEASE
NCT05581628 ·Status: UNKNOWN
-
Choosing a Preferred Serology Kit for Screening and Diagnosis of Celiac Disease
NCT02805816 ·Status: COMPLETED
-
Celiac Disease Diagnosis in Patients With Weakly Positive Serum Anti-Transglutaminase: Duodenal Anti-Endomysium Assay.
NCT02242123 ·Status: COMPLETED
-
Intestinal Transglutaminase Antibodies in Celiac Disease Diagnosis
NCT05810441 ·Status: COMPLETED
-
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
NCT01917630 ·Status: UNKNOWN ·Phase: PHASE2
-
Celiac Disease and Unexplained Iron Deficiency in a Primary Care Setting
NCT02036944 ·Status: TERMINATED
-
Immune Response in Celiac Disease on In-vitro Gluten Challenge
NCT01909050 ·Status: COMPLETED
-
A Study to Evaluate Gluten Challenge on Immune Responses in Subjects With Celiac Disease
NCT03521180 ·Status: COMPLETED
-
MAgnetic Resonance Imaging in COeliac Disease
NCT02551289 ·Status: COMPLETED